Andrew Sullo on Google+
Damages You May Have Suffered as a Result of the Stryker Hip Recall
Perhaps you, like thousands of other consumers, received a Stryker hip device (an ABGII or Rejuvenate) then began having trouble following your implantation. If so, you are probably well aware of the Stryker hip recall which occurred in July, 2012. The Stryker hip recall was issued less than three years after the two devices were launched in February, 2010. At the time the Rejuvenate and ABGII were released, there were high hopes in the industry that there would now be a safer, longer lasting metal hip implant. Stryker’s new hip implants offered surgeons a wide variety of components in different sizes and angles which allowed a custom-fit.
Stryker also used a ceramic ball rather than a metal ball, which was believed to make the two implants considerably safer than most other metal-on-metal devices. Stryker marketed the implants as being ideal for younger, more active patients, and claimed the devices would last much longer (from 15-20 years) than most other hip implants. Patients and surgeons alike were delighted to have a safer alternative to prior hip implants. This made it all the more disappointing when some recipients of the devices began experiencing problems soon after implantation. Surgeons were forced to remove the implants from a number of patients; many of these surgeons noted the clear presence of corrosion on the removed implant, with some stating it looked like “black rust.”
Other surgeons noted the presence of a milky substance in the hip tissues. Patients developed symptoms of metallosis (pain, inflammation, tissue and bone necrosis and total hip failure) as well as symptoms of metal toxicity (DNA changes, pseudo-tumor development, reproductive disorders, headaches, changes to skin and nails, rashes, muscle atrophy, seizures, convulsions, tremors, stroke, heart attack, renal failure, fatigue, poor concentration, vertigo, hearing and vision loss, decline of cognitive functions, depression, anxiety and irritability and hypothyroidism).